ADMINISTRATION - 509 Annonces
401120 Matières premièresSignalez un abus
Thursday 17 July 2025
In industry, sodium hydroxide is usually referred to as caustic soda, or called fire alkali or caustic lime. This is because when a relatively concentrated sodium hydroxide solution splashes onto the skin, it can corrode the epidermis and cause burns. It has a dissolving effect on...
Chongqing Soarwin Technology Co., Ltd
- 401120 - chongqing
- +18 0 99 30 10 07
- +86 19944061337
401000 MédicalSignalez un abus
Thursday 17 July 2025
Etelcalcetide is a novel calcimimetic agent (CalcimeticAgent) that was developed for use in chronic kidney disease (CKD) patients undergoing hemodialysis treatment by intravenous administration.AMG416 binds to and activates calcium-sensitive receptors on the parathyroid glands,...
重庆腾胜盈科技有限公司
- 401000 - 渝北
- +18 7 23 93 07 08
401000 MédicalSignalez un abus
Thursday 17 July 2025
Terlipressin is a new type of synthetic long-acting vasopressin preparation, belonging to a precursor drug, itself inactive, in vivo by the action of aminopeptidase, to remove its N-terminal 3 glycyl residues, slowly “release” the active lysine pressin. It is this “slow release”...
重庆腾胜盈科技有限公司
- 401000 - 渝北
- +18 7 23 93 07 08
401000 Pro / B2BSignalez un abus
Thursday 17 July 2025
The active ingredient of treprostinil is a synthetic analog of gonadotropin-releasing hormone (GnRH), also known as tryptophan, dafylline, dabigatran, gonadorelin, an antitumor drug with the same pharmacological effects as goserelin and buserelin, and its structural improvement...
重庆腾胜盈科技有限公司
- 401000 - 渝北
- +18 7 23 93 07 08
401120 MédicalSignalez un abus
Tuesday 15 July 2025
The active ingredient of treprostinil is a synthetic analog of gonadotropin-releasing hormone (GnRH), also known as tryptophan, dafylline, dabigatran, gonadorelin, an antitumor drug with the same pharmacological effects as goserelin and buserelin, and its structural improvement...
Chongqing Soarwin Technology Co., Ltd
- 401120 - Chongqing
- +12 1 37 59 13 58
401000 Matières premièresSignalez un abus
Tuesday 15 July 2025
The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998,...
重庆腾胜盈科技有限公司
- 401000 - 渝北
- +18 7 23 93 07 08
